Theresa Matkovits
2020
In 2020, Theresa Matkovits earned a total compensation of $1.3M as Chief Development Officer at Matinas BioPharma Holdings, a 79% increase compared to previous year.
Compensation breakdown
| Bonus | $122,500 |
|---|---|
| Option Awards | $763,030 |
| Salary | $367,500 |
| Total | $1,253,030 |
Matkovits received $763K in option awards, accounting for 61% of the total pay in 2020.
Matkovits also received $122.5K in bonus and $367.5K in salary.
Rankings
In 2020, Theresa Matkovits' compensation ranked 7,642nd out of 13,090 executives tracked by ExecPay. In other words, Matkovits earned more than 41.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,642 out of 13,090 | 42nd |
Division Manufacturing | 3,222 out of 5,620 | 43rd |
Major group Chemicals And Allied Products | 1,302 out of 2,253 | 42nd |
Industry group Drugs | 1,127 out of 1,953 | 42nd |
Industry Pharmaceutical Preparations | 840 out of 1,458 | 42nd |
Source: SEC filing on September 22, 2022.
Matkovits' colleagues
We found two more compensation records of executives who worked with Theresa Matkovits at Matinas BioPharma Holdings in 2020.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019